CORD-19:775b90287b44353bee979abb0970a4666022f86d / 650852-651065 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Low threshold for early treatment initiation with IL-1 antagonists is necessary in the setting of persistently elevated inflammatory markers and sterile neutrophilic biopsy without evidence of infectious etiology.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T86992","span":{"begin":0,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T86992","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T137","span":{"begin":0,"end":213},"obj":"Sentence"}],"attributes":[{"subj":"T137","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5023","span":{"begin":145,"end":152},"obj":"Disease"},{"id":"T5024","span":{"begin":193,"end":203},"obj":"Disease"},{"id":"T63084","span":{"begin":145,"end":152},"obj":"Disease"},{"id":"T41403","span":{"begin":193,"end":203},"obj":"Disease"}],"attributes":[{"id":"A5023","pred":"mondo_id","subj":"T5023","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"},{"id":"A5024","pred":"mondo_id","subj":"T5024","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A94560","pred":"mondo_id","subj":"T63084","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"},{"id":"A44744","pred":"mondo_id","subj":"T41403","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"subj":"T5023","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T5024","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T63084","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T41403","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93c5ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#dfec93"},{"id":"CORD-19-PD-MONDO","color":"#de93ec"}]}]}}